A detailed history of Arete Wealth Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Arete Wealth Advisors, LLC holds 1,460 shares of VRTX stock, worth $754,440. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,460
Holding current value
$754,440
% of portfolio
0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$392.81 - $485.53 $573,502 - $708,873
1,460 New
1,460 $684,000
Q4 2023

Feb 14, 2024

BUY
$343.0 - $410.68 $20,237 - $24,230
59 Added 5.8%
1,076 $437,000
Q3 2023

Oct 30, 2023

BUY
$338.18 - $362.46 $48,021 - $51,469
142 Added 16.23%
1,017 $353,000
Q2 2023

Aug 09, 2023

BUY
$314.42 - $351.91 $39,302 - $43,988
125 Added 16.67%
875 $308,000
Q1 2023

May 01, 2023

BUY
$283.23 - $323.1 $212,422 - $242,325
750 New
750 $236,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $133B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Arete Wealth Advisors, LLC Portfolio

Follow Arete Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arete Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arete Wealth Advisors, LLC with notifications on news.